azathioprine has been researched along with Diabetes Mellitus, Type 2 in 16 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the risk of long-term cardiovascular and metabolic outcomes and all-cause mortality in patients with pemphigus managed by rituximab compared with those receiving treatment with first-line corticosteroid-sparing agents (azathioprine and mycophenolate mofetil [MMF])." | 4.31 | Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. ( Kridin, K; Ludwig, RJ; Mruwat, N, 2023) |
| " In summary, mycophenolate mofetil is superior to azathioprine in maintaining remission and preventing relapse in lupus nephritis." | 3.78 | [Nephrology]. ( Martin, PY; Saudan, P, 2012) |
| " We describe a patient suffering from pancytopenia following a combination therapy of azathioprine and allopurinol because of lupus erythematodes and diabetic nephropathy with hyperuricemia." | 3.72 | [Panzytopenia from combination therapy with azathioprin and allopurinol]. ( Seidel, W, 2004) |
| "Diabetes mellitus (DM) has been considered a relative contraindication to heart transplantation (HTx) because of possible increased infection rates and worsening DM with prednisone immunosuppression." | 3.69 | Mid-term results of heart transplantation in diabetic patients. ( Bianco, R; Boffa, GM; Caforio, AL; Casarotto, D; Casula, R; Gambino, A; Grassi, G; Livi, U; Milano, A; Thiene, G, 1994) |
| " The autoimmune hepatitis was treated with prednisolone (initially 60 mg daily, then reduced to 10 mg daily) and azathioprine (initially 100 mg daily, reduced to 50 mg daily)." | 3.69 | [Autoimmune hepatitis, autoimmune gastritis, hypergastrinemia and stomach carcinoid]. ( Ormann, W, 1995) |
| "Type 2 diabetes mellitus is characterized by relative insulin deficiency and insulin resistance." | 1.48 | Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases. ( Anzaldi, L; Fesseha, B; Galiatsatos, P; Kim, HN; Sidhaye, A; Tsao, A, 2018) |
| "Azathioprine was started." | 1.42 | CIDP variants in diabetes: measuring treatment response with a small nerve fiber test. ( Névoret, ML; Vinik, AI, 2015) |
| "Delayed graft function was observed in 34." | 1.38 | Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country. ( Engineer, DP; Godara, SM; Gumber, MR; Jain, SH; Kute, VB; Modi, PR; Munjappa, BC; Patel, HV; Sainaresh, VV; Shah, PR; Shah, VR; Trivedi, HL; Vanikar, AV, 2012) |
| "We report a case of disseminated superficial actinic porokeratosis (DSAP) with neutrophilic pustules within cornoid lamellae on histopathologic examination, corresponding to pustules along the elevated rim clinically as well." | 1.35 | Pustular porokeratosis. ( Miller, DD; Ruben, BS, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Kridin, K | 3 |
| Mruwat, N | 3 |
| Ludwig, RJ | 3 |
| Kim, HN | 1 |
| Fesseha, B | 1 |
| Anzaldi, L | 1 |
| Tsao, A | 1 |
| Galiatsatos, P | 1 |
| Sidhaye, A | 1 |
| Palamuthusingam, D | 1 |
| Mantha, M | 1 |
| Dheda, S | 1 |
| Névoret, ML | 1 |
| Vinik, AI | 1 |
| Wu, PH | 1 |
| Lin, YT | 1 |
| Yang, YH | 1 |
| Lin, YC | 2 |
| Miller, DD | 1 |
| Ruben, BS | 1 |
| Kute, VB | 1 |
| Godara, SM | 1 |
| Shah, PR | 1 |
| Jain, SH | 1 |
| Engineer, DP | 1 |
| Patel, HV | 1 |
| Gumber, MR | 1 |
| Munjappa, BC | 1 |
| Sainaresh, VV | 1 |
| Vanikar, AV | 1 |
| Modi, PR | 1 |
| Shah, VR | 1 |
| Trivedi, HL | 1 |
| Saudan, P | 1 |
| Martin, PY | 1 |
| Seidel, W | 1 |
| Numakura, K | 1 |
| Satoh, S | 1 |
| Tsuchiya, N | 1 |
| Horikawa, Y | 1 |
| Inoue, T | 1 |
| Kakinuma, H | 1 |
| Matsuura, S | 1 |
| Saito, M | 1 |
| Tada, H | 1 |
| Suzuki, T | 1 |
| Habuchi, T | 1 |
| Krendel, DA | 1 |
| Costigan, DA | 1 |
| Hopkins, LC | 1 |
| Livi, U | 1 |
| Caforio, AL | 1 |
| Grassi, G | 1 |
| Boffa, GM | 1 |
| Gambino, A | 1 |
| Milano, A | 1 |
| Bianco, R | 1 |
| Casula, R | 1 |
| Thiene, G | 1 |
| Casarotto, D | 1 |
| Ormann, W | 1 |
| Paterson, AJ | 1 |
| Lamey, PJ | 1 |
| Lewis, MA | 1 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Fonseca, JA | 1 |
| Ianhez, LE | 1 |
| Sabbaga, E | 1 |
| Arap, S | 1 |
| Badellino, MM | 1 |
| Cavarocchi, NC | 1 |
| Narins, B | 1 |
| Jessup, M | 1 |
| Alpern, JB | 1 |
| McClurken, JB | 1 |
| Shuman, CR | 1 |
2 trials available for azathioprine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Renal transplantation in diabetic patients: a survey of 100 cases.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ne | 1992 |
Cardiac transplantation in diabetic patients.
Topics: Antilymphocyte Serum; Azathioprine; Blood Pressure; Cyclosporins; Diabetes Mellitus; Diabetes Mellit | 1990 |
14 other studies available for azathioprine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
Topics: Antibodies; Azathioprine; Cyclophosphamide; Dexamethasone; Diabetes Mellitus, Type 2; Drug Therapy, | 2018 |
HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepa | 2017 |
CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Topics: Autonomic Nervous System; Azathioprine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabet | 2015 |
The increased risk of active tuberculosis disease in patients with dermatomyositis - a nationwide retrospective cohort study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cohort Studies; Databases, Factual; | 2015 |
Pustular porokeratosis.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Human | 2009 |
Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.
Topics: Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Calcineurin Inhibitors; Creatinine; Delaye | 2012 |
[Nephrology].
Topics: Anticholesteremic Agents; Azathioprine; Azetidines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 2012 |
[Panzytopenia from combination therapy with azathioprin and allopurinol].
Topics: Aged; Allopurinol; Antirheumatic Agents; Autoantibodies; Azathioprine; Blood Cell Count; Diabetes Me | 2004 |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
Topics: Adiponectin; Adult; Azathioprine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diabetes M | 2005 |
Successful treatment of neuropathies in patients with diabetes mellitus.
Topics: Aged; Azathioprine; Cyclophosphamide; Demyelinating Diseases; Diabetes Mellitus, Type 1; Diabetes Me | 1995 |
Mid-term results of heart transplantation in diabetic patients.
Topics: Actuarial Analysis; Adult; Azathioprine; Cardiac Catheterization; Coronary Angiography; Cyclosporins | 1994 |
[Autoimmune hepatitis, autoimmune gastritis, hypergastrinemia and stomach carcinoid].
Topics: Autoimmune Diseases; Azathioprine; Carcinoid Tumor; Cholangiopancreatography, Endoscopic Retrograde; | 1995 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |